# Corvus Pharmaceuticals, Inc.: Form SCHEDULE 13D/A, filed Feb 5, 2026

- Company: [Corvus Pharmaceuticals, Inc.](/companies/crvs.md) (CIK 1626971)
- Form: SCHEDULE 13D/A
- Filed: 2026-02-05
- Accepted by EDGAR: Feb 5, 2026, 10:29 ET
- Period: not reported
- Accession: 0001104659-26-010750
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1626971/000110465926010750/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1626971/000110465926010750/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1626971/000110465926010750/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Feb 5, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-010750. Last ingested by Listed: Nov 5, 2026, 16:49 ET. No prices; not investment advice.